| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 CRBM, Université Montpellier 2 et 1, Centre National de la Recherche Scientifique UMR and 2 Institut de Recherche en Cancérologie de Montpellier, Institut National de la Sante et de la Recherche Medicale, Université Montpellier 1, CRLC Val d'Aurelle Paul Lamarque, Montpellier, France
Requests for reprints: Cecile Gauthier-Rouvière, CRBM, Centre National de la Recherche Scientifique, UMR 5237, 1919 Route de Mende, 34293 Montpellier Cedex, France. Phone: 33467613355; Fax: 33467521559; E-mail: cecile.gauthier{at}crbm.cnrs.fr.
Key Words: Cadherins Rac1 GTPase Rhabdomyosarcoma Transformation Myogenesis
Cadherins are transmembrane glycoproteins that mediate Ca2+-dependent homophilic cell-cell adhesion and play a crucial role in proliferation, differentiation, and cell transformation. The goal of this study was to understand why R-cadherin is found in rhabdomyosarcomas (RMS), tumors of skeletal muscle origin, whereas it is absent in normal myoblasts. We show that R-cadherin expression in C2C12 myoblasts causes inhibition of myogenesis induction and impairment of cell cycle exit when cells are cultured in differentiation medium. Furthermore, R-cadherin expression elicits myoblast transformation, as shown by anchorage-independent growth in soft agar in vivo tumor formation assays and increased cell motility. In contrast, inhibition of R-cadherin expression using RNA interference hinders growth of RD cell line in soft agar and its tumorigenicity in mice. The analysis of the nature of R-cadherin–mediated signals shows that R-cadherin–dependent adhesion increases Rac1 activity. Dominant-negative forms of Rac1 inhibit R-cadherin–mediated signaling and transformation. In addition, expression of R-cadherin results in perturbed function of endogenous N-cadherin and M-cadherin. Together, these data suggest that R-cadherin expression inhibits myogenesis and induces myoblast transformation through Rac1 activation. Therefore, the properties of R-cadherin make it an attractive target for therapeutic intervention in RMS. [Cancer Res 2008;68(16):6559–68]
This article has been cited by other articles:
![]() |
G. Agiostratidou, M. Li, K. Suyama, I. Badano, R. Keren, S. Chung, A. Anzovino, J. Hulit, B. Qian, B. Bouzahzah, et al. Loss of Retinal Cadherin Facilitates Mammary Tumor Progression and Metastasis Cancer Res., June 15, 2009; 69(12): 5030 - 5038. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |